These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 19349520)
61. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase. Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388 [TBL] [Abstract][Full Text] [Related]
62. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675. Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966 [TBL] [Abstract][Full Text] [Related]
63. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors. Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952 [TBL] [Abstract][Full Text] [Related]
64. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442 [TBL] [Abstract][Full Text] [Related]
66. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds. Abed Y; Baz M; Boivin G Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366 [TBL] [Abstract][Full Text] [Related]
67. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza. Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654 [TBL] [Abstract][Full Text] [Related]
68. Neuraminidase inhibitors and their role in avian and pandemic influenza. Crusat M; de Jong MD Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267 [TBL] [Abstract][Full Text] [Related]
69. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium. Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705 [TBL] [Abstract][Full Text] [Related]
70. Structural basis for oseltamivir resistance of influenza viruses. Collins PJ; Haire LF; Lin YP; Liu J; Russell RJ; Walker PA; Martin SR; Daniels RS; Gregory V; Skehel JJ; Gamblin SJ; Hay AJ Vaccine; 2009 Oct; 27(45):6317-23. PubMed ID: 19840667 [TBL] [Abstract][Full Text] [Related]
71. Neuraminidase inhibitor resistance in influenza viruses. Reece PA J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169 [TBL] [Abstract][Full Text] [Related]
72. The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern. Schaduangrat N; Phanich J; Rungrotmongkol T; Lerdsamran H; Puthavathana P; Ubol S J Gen Virol; 2016 Jun; 97(6):1311-1323. PubMed ID: 26935590 [TBL] [Abstract][Full Text] [Related]
74. The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity. Jin J; Chen Y; Wang D; Ma L; Guo M; Zhou C; Dou J Arch Pharm Res; 2018 Jun; 41(6):664-676. PubMed ID: 29572682 [TBL] [Abstract][Full Text] [Related]
75. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses. Singh A; Soliman ME Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512 [TBL] [Abstract][Full Text] [Related]
76. Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice. Boltz DA; Ilyushina NA; Arnold CS; Babu YS; Webster RG; Govorkova EA Antiviral Res; 2008 Nov; 80(2):150-7. PubMed ID: 18573280 [TBL] [Abstract][Full Text] [Related]
77. Antiviral management of seasonal and pandemic influenza. Hayden FG; Pavia AT J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384 [TBL] [Abstract][Full Text] [Related]
78. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016. Gubareva LV; Besselaar TG; Daniels RS; Fry A; Gregory V; Huang W; Hurt AC; Jorquera PA; Lackenby A; Leang SK; Lo J; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Odagiri T; Wang D; Zhang W; Meijer A Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866 [TBL] [Abstract][Full Text] [Related]